To further explore the pathway enrichment associated with the regulation of tumor immunity by MICA and MMP9, we performed GSEA using the all differentially expressed genes (FDR q-value < 0.05) obtained from the previous analyses in MICA+ HCC cells and MMP9+ macrophages. The gene discussed is MICA; the disease is neoplasm.